DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Antizol is a drug marketed by Par Pharm Inc and is included in one NDA. There is one patent protecting this drug.
This drug has nine patent family members in eight countries.
The generic ingredient in ANTIZOL is fomepizole. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fomepizole profile page.
A generic version of ANTIZOL was approved as fomepizole by AM REGENT on December 14th, 2007.
Summary for ANTIZOL
Recent Clinical Trials for ANTIZOL
Identify potential brand extensions & 505(b)(2) entrants
|University of Utah||Phase 1|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Par Pharm Inc||ANTIZOL||fomepizole||INJECTABLE;INJECTION||020696-001||Dec 4, 1997||DISCN||Yes||No||Get Started for $10||Get Started for $10||Y||Y||Get Started for $10|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Country||Patent Number||Estimated Expiration|
|China||101163679||Get Started for $10|
|European Patent Office||1948613||Get Started for $10|
|Australia||2006240490||Get Started for $10|
|World Intellectual Property Organization (WIPO)||2006115626||Get Started for $10|
|>Country||>Patent Number||>Estimated Expiration|